Effectiveness and cost-effectiveness of telehealthcare for chronic obstructive pulmonary disease: study protocol for a cluster randomized controlled trial

Flemming Witt Udsen, Pernille Heyckendorff Lilholt, Ole Hejlesen, Lars Holger Ehlers, Flemming Witt Udsen, Pernille Heyckendorff Lilholt, Ole Hejlesen, Lars Holger Ehlers

Abstract

Background: Several feasibility studies show promising results of telehealthcare on health outcomes and health-related quality of life for patients suffering from chronic obstructive pulmonary disease, and some of these studies show that telehealthcare may even lower healthcare costs. However, the only large-scale trial we have so far - the Whole System Demonstrator Project in England - has raised doubts about these results since it conclude that telehealthcare as a supplement to usual care is not likely to be cost-effective compared with usual care alone.

Methods/design: The present study is known as 'TeleCare North' in Denmark. It seeks to address these doubts by implementing a large-scale, pragmatic, cluster-randomized trial with nested economic evaluation. The purpose of the study is to assess the effectiveness and the cost-effectiveness of a telehealth solution for patients suffering from chronic obstructive pulmonary disease compared to usual practice. General practitioners will be responsible for recruiting eligible participants (1,200 participants are expected) for the trial in the geographical area of the North Denmark Region. Twenty-six municipality districts in the region define the randomization clusters. The primary outcomes are changes in health-related quality of life, and the incremental cost-effectiveness ratio measured from baseline to follow-up at 12 months. Secondary outcomes are changes in mortality and physiological indicators (diastolic and systolic blood pressure, pulse, oxygen saturation, and weight).

Discussion: There has been a call for large-scale clinical trials with rigorous cost-effectiveness assessments in telehealthcare research. This study is meant to improve the international evidence base for the effectiveness and cost-effectiveness of telehealthcare to patients suffering from chronic obstructive pulmonary disease by implementing a large-scale pragmatic cluster-randomized clinical trial.

Trial registration: Clinicaltrials.gov, http://NCT01984840, November 14, 2013.

References

    1. Chronic obstructive pulmonary disease (COPD) [ ]
    1. National Institute of Public Health. Eight Diseases Threatening Our Public Health - Prevalence and Development. Copenhagen: ; 2005.
    1. Løkke A, Fabricius PG, Vestbo J, Marott JLLP. Prevalence of COPD in Copenhagen - results from The Copenhagen City Heart Study. Ugeskr Laeger. 2007;169:3956–3960.
    1. COPD in Denmark. [ ]
    1. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: A systematic review and meta-analysis. J Telemed Telecare. 2010;16:120–127. doi: 10.1258/jtt.2009.090812.
    1. Jakobsen AS, Laursen LC, Schou L, Emme C, Phanareth KV. Varying effect of telemedicine in the treatment of chronic obstructive pulmonary disease–a systematic review. Ugeskr Laeger. 2012;174:936–942.
    1. McLean S, Nurmatov U, Liu JL, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;7 CD007718.
    1. De Toledo P, Jiménez S, del Pozo F, Roca J, Alonso A, Hernandez C. Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed. 2006;10:567–573. doi: 10.1109/TITB.2005.863877.
    1. Haesum LKE, Soerensen N, Dinesen B, Nielsen C, Grann O, Hejlesen O, Toft E, Ehlers L. Cost-utility analysis of a telerehabilitation program: A case study of COPD patients. Telemed e-Health. 2012;18:688–692. doi: 10.1089/tmj.2011.0250.
    1. Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Arch Fam Med. 2000;9:40–45. doi: 10.1001/archfami.9.1.40.
    1. Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33:1031–1038. doi: 10.1183/09031936.00063108.
    1. Pare G, Poba-Nzaou P, Sicotte C, Beaupre A, Lefrancois E, Nault D, Saint-Jules D. Comparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: A randomized controlled trial. Eur Res Telemed. 2013;2:35–47. doi: 10.1016/j.eurtel.2013.05.001.
    1. Vitacca M, Bianchi L, Guerra A, Fracchia C, Spanevello A, Balbi B, Scalvini S. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J. 2009;33:411–418.
    1. McLean S, Nurmatov U, Liu JLY, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease: Cochrane Review and meta-analysis. Br J Gen Pract. 2012;62:e739–e749. doi: 10.3399/bjgp12X658269.
    1. Henderson C, Knapp M, Fernández J, Beecham J, Hirani S, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, Doll H, Fitzpatrick R, Steventon A, Bardsley M, Hendy JSN. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f1035. doi: 10.1136/bmj.f1035.
    1. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Fitzpatrick R, Hendy J, Newman S. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874. doi: 10.1136/bmj.e3874.
    1. National Board of eHealth. National Strategy for Digitalisation of the Danish Healthcare Sector 2013-2017. Copenhagen: ; 2013.
    1. Global initiative for Chronic Obstructive Lung disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013. [ ]
    1. Dinesen B, Haesum LKE, Soerensen N, Nielsen C, Grann O, Hejlesen O, Toft E, Ehlers LH. Using preventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients. J Telemed Telecare. 2012;18:221–225. doi: 10.1258/jtt.2012.110704.
    1. Bentsen SB, Rokne B, Wahl AK. Comparison of health-related quality of life between patients with chronic obstructive pulmonary disease and the general population. Scand J Caring Sci. 2013;27:905–912. doi: 10.1111/scs.12002.
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661–e5661. doi: 10.1136/bmj.e5661.
    1. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;339:b2393.
    1. Wittrup-Jensen K, Lauridsen J, Gudex C, Pedersen K. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009;37:459–466. doi: 10.1177/1403494809105287.
    1. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. Third edit. New York: Oxford University Press; 2005.
    1. Work Productivity and Activity Impairment Questionnaire. [ ]
    1. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. New York: Oxford University Press; 2006.
    1. Glick H, Doshi J, Sonnad S, Polsky D. Economic Evaluation in Clinical Trials. New York: Oxford University Press; 2007.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere